Annual CFF
$59.55 M
+$59.05 M+11809.60%
December 31, 2023
Summary
- As of February 7, 2025, JANX annual cash flow from financing activities is $59.55 million, with the most recent change of +$59.05 million (+11809.60%) on December 31, 2023.
- During the last 3 years, JANX annual CFF has risen by +$48.02 million (+416.73%).
- JANX annual CFF is now -84.59% below its all-time high of $386.52 million, reached on December 31, 2021.
Performance
JANX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$1.65 M
-$1.12 M-40.36%
September 30, 2024
Summary
- As of February 7, 2025, JANX quarterly cash flow from financing activities is $1.65 million, with the most recent change of -$1.12 million (-40.36%) on September 30, 2024.
- Over the past year, JANX quarterly CFF has dropped by -$54.96 million (-97.09%).
- JANX quarterly CFF is now -99.50% below its all-time high of $329.66 million, reached on June 30, 2021.
Performance
JANX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$327.42 M
-$54.96 M-14.37%
September 30, 2024
Summary
- As of February 7, 2025, JANX TTM cash flow from financing activities is $327.42 million, with the most recent change of -$54.96 million (-14.37%) on September 30, 2024.
- Over the past year, JANX TTM CFF has increased by +$268.51 million (+455.81%).
- JANX TTM CFF is now -16.42% below its all-time high of $391.72 million, reached on June 30, 2021.
Performance
JANX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
JANX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | -97.1% | +455.8% |
| 3 y3 years | +416.7% | +295.6% | -16.2% |
| 5 y5 years | +1388.7% | +9.6% | +10000.0% |
JANX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -84.6% | >+9999.0% | -99.5% | -100.0% | -15.3% | >+9999.0% |
| 5 y | 5-year | -84.6% | >+9999.0% | -99.5% | +295.6% | -16.4% | >+9999.0% |
| alltime | all time | -84.6% | >+9999.0% | -99.5% | +295.6% | -16.4% | >+9999.0% |
Janux Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.65 M(-40.4%) | $327.42 M(-14.4%) |
| Jun 2024 | - | $2.77 M(-99.1%) | $382.38 M(+0.6%) |
| Mar 2024 | - | $322.17 M(>+9900.0%) | $380.14 M(+538.4%) |
| Dec 2023 | $59.55 M(>+9900.0%) | $831.00 K(-98.5%) | $59.55 M(+1.1%) |
| Sep 2023 | - | $56.61 M(>+9900.0%) | $58.91 M(+2462.3%) |
| Jun 2023 | - | $528.00 K(-66.6%) | $2.30 M(+10.6%) |
| Mar 2023 | - | $1.58 M(+727.2%) | $2.08 M(+315.8%) |
| Dec 2022 | $500.00 K | $191.00 K(>+9900.0%) | $500.00 K(+5.7%) |
| Sep 2022 | - | $0.00(-100.0%) | $473.00 K(-227.8%) |
| Jun 2022 | - | $308.00 K(>+9900.0%) | -$370.00 K(-100.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1000.00(-99.4%) | $328.98 M(-14.9%) |
| Dec 2021 | $386.52 M(+3254.1%) | $164.00 K(-119.5%) | $386.52 M(-1.1%) |
| Sep 2021 | - | -$843.00 K(-100.3%) | $390.91 M(-0.2%) |
| Jun 2021 | - | $329.66 M(+472.9%) | $391.72 M(+479.8%) |
| Mar 2021 | - | $57.55 M(+1163.9%) | $67.57 M(+486.3%) |
| Dec 2020 | $11.52 M(+188.1%) | $4.55 M(<-9900.0%) | $11.52 M(+65.3%) |
| Sep 2020 | - | -$33.00 K(-100.6%) | $6.97 M(-0.5%) |
| Jun 2020 | - | $5.50 M(+265.7%) | $7.00 M(+365.7%) |
| Mar 2020 | - | $1.50 M | $1.50 M |
| Dec 2019 | $4.00 M | - | - |
FAQ
- What is Janux Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Janux Therapeutics?
- What is Janux Therapeutics annual CFF year-on-year change?
- What is Janux Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Janux Therapeutics?
- What is Janux Therapeutics quarterly CFF year-on-year change?
- What is Janux Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Janux Therapeutics?
- What is Janux Therapeutics TTM CFF year-on-year change?
What is Janux Therapeutics annual cash flow from financing activities?
The current annual CFF of JANX is $59.55 M
What is the all time high annual CFF for Janux Therapeutics?
Janux Therapeutics all-time high annual cash flow from financing activities is $386.52 M
What is Janux Therapeutics annual CFF year-on-year change?
Over the past year, JANX annual cash flow from financing activities has changed by +$59.05 M (+11809.60%)
What is Janux Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of JANX is $1.65 M
What is the all time high quarterly CFF for Janux Therapeutics?
Janux Therapeutics all-time high quarterly cash flow from financing activities is $329.66 M
What is Janux Therapeutics quarterly CFF year-on-year change?
Over the past year, JANX quarterly cash flow from financing activities has changed by -$54.96 M (-97.09%)
What is Janux Therapeutics TTM cash flow from financing activities?
The current TTM CFF of JANX is $327.42 M
What is the all time high TTM CFF for Janux Therapeutics?
Janux Therapeutics all-time high TTM cash flow from financing activities is $391.72 M
What is Janux Therapeutics TTM CFF year-on-year change?
Over the past year, JANX TTM cash flow from financing activities has changed by +$268.51 M (+455.81%)